Skip to content

Treatment Of Leucoderma By Ammi Visnaga

A Clinical Trial On The Efficacy Of Ammi Visnaga In The Treatment Of Leucoderma - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053856
Enrollment
35
Registered
2023-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L815- Leukoderma, not elsewhere classified

Interventions

Intervention1: Ammi visnaga Mother Tincture: 5 Drops In 10 Ml of Water Daily For 7 Days Repeated At 15 Days Interval Control Intervention1: Not Applicable: Not Applicable

Sponsors

RBTS Government Homoeopathic Medical College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All age groups Self reported and pre diagnosed cases of Leucoderma Patients with signs and symptomatology of Leucoderma Cases confirmed by Woods lamp examination

Exclusion criteria

Exclusion criteria: Patients or its guardian unwilling to take part or not giving consent to join the study Diagnosed cases of systemic diseases psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure Age less than 06 months Substance abuse or dependence Self reported immune compromised state

Design outcomes

Primary

MeasureTime frame
Improvement in their symptomatology. Improvement in Vitiligo Area Scoring Index VASITimepoint: 1 month to 3 months

Secondary

MeasureTime frame
Improvement in their symptomatology Improvement in Vitiligo Disease Activity Score VIDA Improvement in DLQI Score Timepoint: 3 to 6 months

Countries

India

Contacts

Public ContactDr Nirbhay Kumar

RBTS Government Homoeopathic Medical College And Hospital Muzaffarpur

drgkeshav.257@gmail.com8984681057

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026